On Monday, FDA announced two warning letters issued to makers of topical CBD products labeled as OTC drugs. Amidst a backdrop of facility inspections that revealed significant good manufacturing compliance concerns, the most important takeaways in this round of CBD
Continue Reading FDA Enforcement: There’s Nothing Inactive About CBD and “FDA Registered” Is Misleading
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:FTC Approves Final Administrative Consent Orders against Sellers of Deceptively Marketed CBD Products
Following a public comment period, the Federal Trade Commission has approved final administrative